IQVIA Featured Articles

1. Can Decentralized Clinical Trials Solve Attrition? Early Research Suggests ‘Yes.’ 3/12/2021

   Patient attrition has always been a challenge in clinical research, but the use of decentralized clinical trials (DCTs) may help sponsors overcome attrition problems. Learn what clinical trial models can bolster retention and greater engagement between patients, investigators and sponsors.   

2. Partnerships In The Pandemic: Deploying eConsent For Remote And Hybrid Studies 12/7/2020

   This 20-minute webinar gives the latest information from hands-on experience with eConsent implementations for new and ongoing trials in the COVID-19 era. Learn about the benefits that can be gained from remote consent for patients and sites and the changing regulatory landscape that is enabling adoption in a growing number of countries and regions.

3. Will Virtual Trials Mean The End Of CROs? 11/4/2019

   Virtual trials are growing in acceptance. The patient-centric aspect of these trials makes them easier to recruit and retain patients and accelerate timelines, while also providing patient data to researchers in real time. But will virtual trials also mean the end of CROs?

4. Virtual Absolution: How Trial Sites Adapted To COVID-19 2/4/2021

   COVID-19 accelerated interest in the use of virtual trials as a way to keep trials running through the pandemic. It was an unexpected shift, but it has helped many sponsors and sites see the value of virtual for clinical research and identify where and when virtual trial elements may bring permanent benefits to clinical research, even after the pandemic is over.

5. Delivering Clinical Trial Continuity During COVID-19 2/4/2021

   The global pandemic has added complexity to the already nuanced clinical development landscape, making innovation within clinical research critical to advancing human health. There are many factors that play a role in how trial adjustments are implemented. This paper will discuss how clinical trial models are evolving as sponsors rethink the traditional research paradigm and adopt patient-centric clinical technologies and approaches, including telemedicine and remote clinical monitoring.

6. Remote Consent: Adjusting To The New Normal In Clinical Trials 6/3/2020

   The global pandemic has brought the need to enrol new patients quickly in COVID19-related trials and keep patient engagement high in ongoing trials, even as face-to-face interactions are limited. This presentation will review sponsor and site frequently asked questions about electronic and remote consent capabilities as they seek to consent patients in new and faster ways.